Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Malignant Lymphoma

  Free Subscription


13.07.2026

1 Blood
2 Bone Marrow Transplant
6 Br J Haematol
1 Cancer
3 Haematologica
1 J Clin Oncol
1 Leuk Lymphoma
3 Leukemia


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Blood

  1. CHIHARA D, Westin JR
    The Chaos of Choice in Large B-cell Lymphoma: A Call to Harmonize First-line Trial Design.
    Blood. 2026 Jul 6:blood.2026034393. doi: 10.1182/blood.2026034393.
    PubMed         Abstract available


    Bone Marrow Transplant

  2. DREGER P, Iacoboni G, Robinson S, Bazarbachi A, et al
    Cellular therapy in mantle cell lymphoma: recommendations from the EBMT practice harmonisation and guidelines committee.
    Bone Marrow Transplant. 2026 Jul 9. doi: 10.1038/s41409-026-02963.
    PubMed         Abstract available

  3. TU J, Zou R, Ping N, Zhu Q, et al
    Epigenetic priming with azacitidine-BEAM versus decitabine-BEAM conditioning for autologous transplantation in non-Hodgkin's lymphoma.
    Bone Marrow Transplant. 2026 Jul 6. doi: 10.1038/s41409-026-02967.
    PubMed        


    Br J Haematol

  4. CASEY DL, Renfro LA, Wu Y, McCarten K, et al
    Patterns of presentation and outcomes in stage IV Hodgkin lymphoma: A report from the Children's Oncology Group (COG) AHOD1331 trial.
    Br J Haematol. 2026 Jul 8. doi: 10.1111/bjh.70625.
    PubMed         Abstract available

  5. HUNZEKER Z, de la Rosa FJ, Tyshevich A, Shavronskaya D, et al
    Mechanisms of resistance to macrophage checkpoint inhibitors in B-cell non-Hodgkin lymphoma for the British Journal of Haematology.
    Br J Haematol. 2026 Jul 7. doi: 10.1111/bjh.70668.
    PubMed        

  6. YANG CF, Yeh YC, Hsu CY
    Prognostic impact of germline and somatic variants in lymphoma-associated haemophagocytic lymphohistiocytosis.
    Br J Haematol. 2026 Jul 7. doi: 10.1111/bjh.70674.
    PubMed         Abstract available

  7. VILLENEUVE PJA, Mozessohn L, Some NH, Mercer RE, et al
    Comparative effectiveness of chimeric antigen receptor (CAR) T-cell therapy versus historical controls in patients with relapse/refractory aggressive B-cell lymphoma: An indirect treatment comparison in the real-world setting.
    Br J Haematol. 2026 Jul 6. doi: 10.1111/bjh.70632.
    PubMed         Abstract available

  8. MARCHISIO S, Yakymiv Y, Lin L, Ortolan E, et al
    Utility of combined CD39/CD73/CD38 expression for the detection of malignant T cells in Sezary syndrome.
    Br J Haematol. 2026;209:42-53.
    PubMed         Abstract available

  9. FALL C, Daudignon A, Valmary-Degano S, Mondet J, et al
    Optical genome mapping improves detection and characterisation of cytogenetic abnormalities in non-Hodgkin lymphomas.
    Br J Haematol. 2026;209:31-41.
    PubMed         Abstract available


    Cancer

  10. OLIVIERI J, Gattei V, Dal Maso L
    Bendamustine in indolent lymphoma: Letting the dust settle down.
    Cancer. 2026;132:e70527.
    PubMed        


    Haematologica

  11. GALTIER J, Basile G, Bouabdallah K
    Response to comment on: "Brentuximab-vedotin and bendamustine for relapsed or refractory Hodgkin lymphoma: the LYSA real-world experience".
    Haematologica. 2026 Jul 9. doi: 10.3324/haematol.2026.301477.
    PubMed         Abstract available

  12. TADMOR T
    A ray of hope for early-stage T-cell lymphoma.
    Haematologica. 2026 Jul 9. doi: 10.3324/haematol.2026.301390.
    PubMed         Abstract available

  13. LI R, Sheng L, Ma J, Lu X, et al
    Dual resistance to asparaginase and PD-1 blockade in extranodal natural killer/T-cell lymphoma: dismal outcomes from a multicenter cohort.
    Haematologica. 2026 Jul 9. doi: 10.3324/haematol.2026.300670.
    PubMed         Abstract available


    J Clin Oncol

  14. MATASAR M, Li Z, Vassilakopoulos TP, Sancho JM, et al
    Polatuzumab Vedotin Plus Rituximab, Gemcitabine, and Oxaliplatin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Results From the Phase III, Randomized POLARGO Trial.
    J Clin Oncol. 2026 Jul 6:JCO2502849. doi: 10.1200/JCO-25-02849.
    PubMed         Abstract available


    Leuk Lymphoma

  15. OURA M, Ikeda D, Uehara A, Tabata R, et al
    Extending the prognostic value of red cell distribution width to nodal T follicular helper cell lymphoma.
    Leuk Lymphoma. 2026 Jul 7:1-4. doi: 10.1080/10428194.2026.2697464.
    PubMed        


    Leukemia

  16. YAO Y, Fei Y, Yan F, Li X, et al
    Reversible and irreversible BTK inhibition promotes stem-like functional multipotency, persistence, and antitumor efficacy of CD19-directed CAR T cells in mantle cell lymphoma.
    Leukemia. 2026 Jul 9. doi: 10.1038/s41375-026-03032.
    PubMed        

  17. LIPPL J, Reinke S, Koch K, Oschlies I, et al
    Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.
    Leukemia. 2026 Jul 7. doi: 10.1038/s41375-026-03036.
    PubMed         Abstract available

  18. TERZIEV D, Schumann FL, Behlendorf T, Brunner F, et al
    Retroperitoneal bulk predicts chylothorax in follicular lymphoma-control requires systemic response.
    Leukemia. 2026 Jul 6. doi: 10.1038/s41375-026-03025.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum